Company: BCS
Filing Date: 2025-02-20
Form Type: 424B2
Source: 0001193125-25-030302
Chunk: 90

Company: BARCLAYS PLC
Filing Date: 2025-02-20
Form: 424B2
Chunk 90
---
, this prospectus supplement will prevail with regard to the Securities.

The Securities will constitute a series of Contingent Capital Securities issued under the Contingent Capital Securities Indenture dated as of
August 14, 2018 among us and The Bank of New York Mellon, London Branch, as Trustee and The Bank of New York Mellon SA/NV, Luxembourg Branch, as Contingent Capital Security Registrar (as heretofore supplemented and amended, the “Base
Indenture”), as further supplemented by the twelfth supplemental indenture expected to be entered into on February 25, 2025 (the “Twelfth Supplemental Indenture,” and together with the Base Indenture, the “Indenture”). The
terms of the Securities include those stated in the Indenture and any supplements thereto, and those terms made part of the Indenture by reference to the Trust Indenture Act. Certain terms used in this prospectus supplement, unless otherwise defined
herein, have the meaning given to them in the Indenture. We filed the Contingent Capital Securities Indenture dated as of August 14, 2018 as an exhibit to the Form 6-K filed on August 14, 2018 (Film
No. 181018017), and will file the Twelfth Supplemental Indenture as an exhibit to a report on Form 6-K on or about February 25, 2025.

The shareholders of the Issuer passed an ordinary resolution on May 9, 2024 to increase its share capital by the creation of new shares
of up to £825,000,000 in relation to any issue of securities that automatically convert into or are exchanged for ordinary shares of the Issuer in prescribed circumstances where the directors of the Issuer consider that such an issuance of
securities would be desirable in connection with, or for the purposes of, complying with or maintaining compliance with regulatory capital requirements or targets applicable to the Group from time to time, which authorization expires at the end of
the Issuer’s Annual General Meeting to be held in 2025 or the close of business on June 30, 2025 (whichever is earlier), unless otherwise renewed or passed pursuant to a separate resolution.

The Securities will be issued in an aggregate principal amount of $1,500,000,000 and will have no fixed maturity or fixed redemption date.
From (and including) the Issue Date to (but excluding) September 15, 203